tiprankstipranks
Advertisement
Advertisement

TSE:MSCL Stock Latest News

Satellos resumed with a Speculative Buy at Canaccord
The FlySatellos resumed with a Speculative Buy at Canaccord
2d ago
MSLE
Satellos Bioscience Sets June 17, 2026 Virtual Annual Shareholder Meeting
PremiumCompany Announcements
Satellos Bioscience Sets June 17, 2026 Virtual Annual Shareholder Meeting
3d ago
6K
MSLE
Satellos reports Q1 EPS (53c), consensus (59c)
PremiumThe Fly
Satellos reports Q1 EPS (53c), consensus (59c)
8d ago
MSLE
Satellos Bioscience Posts Wider Q1 2026 Loss but Strengthens Balance Sheet
PremiumCompany Announcements
Satellos Bioscience Posts Wider Q1 2026 Loss but Strengthens Balance Sheet
8d ago
6K
MSLE
Satellos initiated with a Buy at Guggenheim
PremiumThe Fly
Satellos initiated with a Buy at Guggenheim
25d ago
MSLE
Satellos Bioscience to Showcase DMD Program at April Bloom Burton Healthcare Investor Conference
PremiumCompany AnnouncementsSatellos Bioscience to Showcase DMD Program at April Bloom Burton Healthcare Investor Conference
1M ago
6K
MSLE
Satellos management to meet with Oppenheimer
Premium
The Fly
Satellos management to meet with Oppenheimer
1M ago
MSLE
Satellos initiated with an Outperform at Leerink
Premium
The Fly
Satellos initiated with an Outperform at Leerink
2M ago
MSLE
Satellos has ‘catalyst-rich; 2026, says H.C. Wainwright
PremiumThe Fly
Satellos has ‘catalyst-rich; 2026, says H.C. Wainwright
2M ago
MSLE
Satellos Bioscience Posts 2025 Results, Advances SAT-3247 Into Global Phase 2 Duchenne Trials
PremiumCompany Announcements
Satellos Bioscience Posts 2025 Results, Advances SAT-3247 Into Global Phase 2 Duchenne Trials
2M ago
6K
MSLE
Cantor starts Satellos with an Overweight on DMD therapy potential
PremiumThe Fly
Cantor starts Satellos with an Overweight on DMD therapy potential
2M ago
MSLE
Satellos initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Satellos initiated with an Overweight at Cantor Fitzgerald
2M ago
MSLE
Satellos Bioscience Inc. Common Stock trading resumes
PremiumThe FlySatellos Bioscience Inc. Common Stock trading resumes
2M ago
MSLE
Satellos Bioscience Inc. Common Stock trading halted, volatility trading pause
Premium
The Fly
Satellos Bioscience Inc. Common Stock trading halted, volatility trading pause
2M ago
MSLE
Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026
Premium
Company Announcements
Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026
2M ago
6K
MSLE
Satellos presents interim SAT-3247 data at MDA Conference
PremiumThe Fly
Satellos presents interim SAT-3247 data at MDA Conference
2M ago
MSLE
Satellos to Showcase New SAT-3247 DMD and FSHD Data at 2026 MDA Conference
PremiumCompany Announcements
Satellos to Showcase New SAT-3247 DMD and FSHD Data at 2026 MDA Conference
3M ago
6K
MSLE
Satellos Bioscience to Court Investors as Phase 2 DMD Program Advances
PremiumCompany Announcements
Satellos Bioscience to Court Investors as Phase 2 DMD Program Advances
3M ago
6K
MSLE
Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy
PremiumCompany Announcements
Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy
3M ago
6K
MSLE
Satellos to Highlight Duchenne Drug Program at Series of Investor Conferences
PremiumCompany AnnouncementsSatellos to Highlight Duchenne Drug Program at Series of Investor Conferences
3M ago
MSLE
Satellos Bioscience Doses First Patient in Phase 2 Pediatric Duchenne Study of SAT-3247
Premium
Company Announcements
Satellos Bioscience Doses First Patient in Phase 2 Pediatric Duchenne Study of SAT-3247
3M ago
6K
MSLE
Satellos price target raised to $40 from $5 at Oppenheimer
Premium
The Fly
Satellos price target raised to $40 from $5 at Oppenheimer
3M ago
MSLE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >